2 months ago
Learn about an Idiopathic Pulmonary Fibrosis (IPF) Research Study Now Enrolling Locally.
Clinical trials or studies are important for medical advances. Current treatments for diseases are only available because of research study volunteers.
Although much IPF research has been done, current treatment options remain limited. However, the GALACTIC-1 study is researching treatment for these patients and may offer new hope in IPF. Thank you for considering participation in this trial.
GALACTIC-1 is studying an investigational drug for patients who have IPF. The purpose of this study is to find out if the investigational drug works and to determine its safety.
You may qualify for this study if:
• You are between 40 and 90 years of age
• You have been diagnosed with Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis (IPF) patients and their loved ones are invited to learn about the GALACTIC-1 study by visiting Galactic1IPFStudy.com. ... See MoreSee Less
4 months ago
WE ARE LOOKING FOR WOMEN OF A...ahem...*CERTAIN AGE*...WHO HAVE HOTFLASHES! CALL 334-504-7020! ... See MoreSee Less
Currently enrolling people in studies for COPD, asthma, endometriosis, uterine fibroids, heart failure, and more! ... See MoreSee Less
2 years ago
Here's the one who started it all: our principle Principle Investigator, Dr. Rob Garver, founder/owner of both SEC Lung and SEC Clinical Research. Dr. Garver has been practicing medicine for over 30 years, including 20 years as an attending physician/Professor of Medicine at UAB Hospital in Birmingham, AL. He attended medical school at The Johns Hopkins School of Medicine, where he also completed his Internal Medicine training. He completed his Pulmonary Fellowship at the National Heart, Lung, and Blood Institute and his Critical-Care Medicine Fellowship at UAB. Dr. Garver has been working as a PI for over five years and has participated in numerous research protocols, including COPD, COPD exacerbation, asthma, asthma exacerbation, endometriosis, uterine fibroids, congestive heart failure, and chronic kidney disease ... See MoreSee Less